Skip to content

Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2017 Financial Results
- Clinical Data from Multiple Phase 2 Development Programs Expected in 2017 -<br>- Ralinepag Phase 2 Study Results Expected in July -
View HTML
Toggle Summary Arena Pharmaceuticals to Release First Quarter 2017 Financial Results and Provide Corporate Update on Tuesday, May 9, 2017
SAN DIEGO , May 2, 2017 /PRNewswire/ --  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic areas, today announced that the Company will release its first quarter 2017 financial results and provide a
View HTML
Toggle Summary Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results
- Clinical Data from Multiple Phase 2 Development Programs Expected in 2017 -
View HTML
Toggle Summary Arena Pharmaceuticals to Provide Corporate Update and Release Fourth Quarter and Full-Year 2016 Financial Results on Tuesday, March 14, 2017
SAN DIEGO , March 06, 2017 (GLOBE NEWSWIRE) -- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), today announced that the Company will provide a corporate update and release its fourth quarter and full-year 2016 financial results on Tuesday, March 14, 2017 , after the close of the U.S.
View HTML
Toggle Summary Arena Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update
- Clinical Data from Phase 2 Development Programs Expected in 2017 -
View HTML
Toggle Summary Arena Pharmaceuticals to Release Third Quarter 2016 Financial Results and Provide Corporate Update on Monday, November 7, 2016
SAN DIEGO , Oct. 31, 2016 /PRNewswire/ -- Arena Pharmaceuticals, Inc. ( NASDAQ : ARNA), today announced that the Company will release its third quarter 2016 financial results and provide a corporate update on Monday, November 7, 2016 , after the close of the U.S.
View HTML
Toggle Summary Arena Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update
- Advancing Three Phase 2 Clinical Candidates -<br>- Conference Call and Webcast Scheduled for Today at 4:30 p.m. Eastern Time -
View HTML
Toggle Summary Arena Pharmaceuticals to Release Second Quarter 2016 Financial Results and Provide Corporate Update on Monday, August 8, 2016
SAN DIEGO , Aug. 1, 2016 /PRNewswire/ --  Arena Pharmaceuticals, Inc. ( NASDAQ : ARNA), today announced that the Company will release its second quarter 2016 financial results and provide a corporate update on Monday, August 8, 2016 , after the close of the U.S.
View HTML
Toggle Summary Arena Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Corporate Update
- Biopharmaceutical Industry Veteran Amit Munshi Appointed Chief Executive Officer -<br>- Conference Call and Webcast Scheduled for Today at 5:00 p.m. Eastern Time -
View HTML
Toggle Summary Arena Pharmaceuticals to Host First Quarter 2016 Financial Results and Corporate Update Conference Call and Webcast on Monday, May 9
SAN DIEGO , May 2, 2016 /PRNewswire/ --  Arena Pharmaceuticals, Inc. ( NASDAQ : ARNA) today announced that it will host a conference call and webcast at 5:00 p.m. Eastern Time ( 2:00 p.m. Pacific Time ) on Monday, May 9, 2016 , to discuss first quarter 2016 financial results and provide a corporate
View HTML